US › Healthcare

Connect Biopharma Holdings Ltd (CNTB)

US · Healthcare · Biotechnology

$2.07+5.08%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$169,000

Net profit

$-19.4M

Profit YoY

-88.8%

EPS

$-0.27

EPS estimate

$-0.28

Net margin

-11,478.1%

EPS came in at -0.27 against a street estimate of -0.28 — a beat of 4.6%.

Key statistics

Market cap

$127.2M

Forward P/E

0.8

P/B

2.98

Book value

$0.68

EPS (TTM)

$-1.15

52-week high

$3.82

52-week low

$1.23

50-day MA

$2.23

200-day MA

$2.40

Beta

-0.18

Analyst view

Analysts rate Connect Biopharma Holdings Ltd a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $7.12.

Shareholding

Insiders

31.82%

Institutions

55.82%

Largest institutional holders

Fund	Stake
EverSource Wealth Advisors, LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Connect Biopharma Holdings Ltd — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.